Patients with CML express BCR-ABL, which increases proliferation, whereas AML patients express NUP98-HOXA9, which increases self-renewal in hematopoietic stem cells and causes a more malignant form of leukemia [7]. This evidence concerns the gene HOXA9 and chronic myelogenous leukemia, BCR-ABL1 positive.